Induction of apoptosis by piperine in human cervical adenocarcinoma via ROS mediated mitochondrial pathway and caspase-3 activation.

Clicks: 235
ID: 33120
2019
Piperine (1-piperoylpeperdine), a nitrogenous pungent substance, is present in the fruits of black pepper ( Linn.) and long pepper ( Linn.). It possesses several pharmacological properties and has been extensively explored for its anti-cancerous activities. The mechanism underlying its anti-cancer potential in human cervical adenocarcinoma (HeLa) cells is not well interpreted. The anti-proliferative effect and the mode of action of piperine were investigated through some potent markers of apoptosis reactive oxygen species (ROS) generation, cellular apoptosis and loss of mitochondrial membrane potential (MMP). DNA fragmentation, cell cycle kinetics, caspase-3 activity and cell migration assays were also conducted to observe the efficacy of piperine against HeLa cells. The results showed that piperine exposure induces apoptosis significantly in a dose-dependent manner and inhibits the growth of HeLa cells with an increase in ROS generation, nuclear condensation and delayed wound healing. In addition, piperine also encourages cell death by the loss of MMP, DNA fragmentation and the activation of caspase-3. Growth inhibition of HeLa cells was found to be associated with G2/M phase arrest and sub-G1 accumulation. The present study provides useful insight into the apoptotic potential of piperine and further and clinical studies will be needed for its validation and in the finding of more effective and least toxic regimens against cervical cancer.
Reference Key
jafri2019inductionexcli Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jafri, Asif;Siddiqui, Sahabjada;Rais, Juhi;Ahmad, Md Sultan;Kumar, Sudhir;Jafar, Tabrez;Afzal, Mohammad;Arshad, Md;
Journal excli journal
Year 2019
DOI 10.17179/excli2018-1928
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.